News: Inditherm secure sizeable orders
Innovative Rotherham company, Inditherm, saw losses increase for 2012 but has also seen sizeable orders placed in the first quarter of 2013.
The AIM-listed Manvers firm is the only UK manufacturer of patient warming systems and has developed products using low voltage carbon polymer technology to provide heat. Its systems are used for patients undergoing operations which carry risk of inadvertent hypothermia and in neonatal wards.
In its latest results to December 31 2012, Inditherm reported that turnover had remained roughly the same at £1.7m with sales also similar to those of the prior year, up slightly to £1.67m. But post-tax losses increased to £164,000 from £108,000 in 2011 due to investment to support future growth.
The board is confident that the investment will pay off as the manufacturing organisation was put in place in order to meet future orders, which have now been received.
Economic conditions and delays with decision making in the NHS hit profits but orders expected to be received in 2012 were delayed and received in early 2013.
Mark Abrahams, chairman of Inditherm, said: "It is our belief that the increased order conversion lead-times we saw in 2012 were caused by general and specific economic circumstances rather than a dampening of enthusiasm for our products.
"We have seen some sizeable orders placed in the first quarter of 2013, some delayed from last year along with business originally expected later in the year. The Company has enjoyed a profitable start to the current year and this gives us cause to be optimistic that we can return to a more attractive growth rate."
Despite delays, Inditherm managed to grow UK order levels by just under 10% in 2012, helped by strong performance in the neonatal sector. An increasing number of NHS hospitals are now using Inditherm as their primary surgical patient warming system.
The company has benefited from an increase in export orders in previous years but 2012 saw a lack of order growth. Inditherm has started to address territories where partners are under-performing.
Inditherm also launched a number of new products recently including a range of accessories for use by neonatal units and the new "LifeStart" system, launched at the 2013 Arab Health exhibition, that facilitates the delaying of the clamping and cutting of the umbilical cord following childbirth by providing resuscitation at a newborn baby's bedside.
Working with with other manufacturers, Inditherm expects to see partners' product launches towards the end of 2013. With new products using Inditherm's technology, the move offers good potential for additional growth for the future, and wider brand recognition.
Inditherm website
Images: Inditherm
The AIM-listed Manvers firm is the only UK manufacturer of patient warming systems and has developed products using low voltage carbon polymer technology to provide heat. Its systems are used for patients undergoing operations which carry risk of inadvertent hypothermia and in neonatal wards.
In its latest results to December 31 2012, Inditherm reported that turnover had remained roughly the same at £1.7m with sales also similar to those of the prior year, up slightly to £1.67m. But post-tax losses increased to £164,000 from £108,000 in 2011 due to investment to support future growth.
The board is confident that the investment will pay off as the manufacturing organisation was put in place in order to meet future orders, which have now been received.
Economic conditions and delays with decision making in the NHS hit profits but orders expected to be received in 2012 were delayed and received in early 2013.
Mark Abrahams, chairman of Inditherm, said: "It is our belief that the increased order conversion lead-times we saw in 2012 were caused by general and specific economic circumstances rather than a dampening of enthusiasm for our products.
"We have seen some sizeable orders placed in the first quarter of 2013, some delayed from last year along with business originally expected later in the year. The Company has enjoyed a profitable start to the current year and this gives us cause to be optimistic that we can return to a more attractive growth rate."
Despite delays, Inditherm managed to grow UK order levels by just under 10% in 2012, helped by strong performance in the neonatal sector. An increasing number of NHS hospitals are now using Inditherm as their primary surgical patient warming system.
The company has benefited from an increase in export orders in previous years but 2012 saw a lack of order growth. Inditherm has started to address territories where partners are under-performing.
Inditherm also launched a number of new products recently including a range of accessories for use by neonatal units and the new "LifeStart" system, launched at the 2013 Arab Health exhibition, that facilitates the delaying of the clamping and cutting of the umbilical cord following childbirth by providing resuscitation at a newborn baby's bedside.
Working with with other manufacturers, Inditherm expects to see partners' product launches towards the end of 2013. With new products using Inditherm's technology, the move offers good potential for additional growth for the future, and wider brand recognition.
Inditherm website
Images: Inditherm
0 comments:
Post a Comment